LIST OF TABLES

TABLE 01.BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 ($THOUSAND)
TABLE 02.BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 (UNITS)
TABLE 03.REAGENT KITS BREAST CANCER LIQUID BIOPSY MARKET, BY REGION, 2019-2027 ($THOUSAND)
TABLE 04.REAGENT KITS BREAST CANCER LIQUID BIOPSY MARKET, BY REGION, 2019-2027 (UNITS)
TABLE 05.INSTRUMENTS BREAST CANCER LIQUID BIOPSY MARKET, BY REGION, 2019-2027 ($THOUSAND)
TABLE 06.INSTRUMENTS BREAST CANCER LIQUID BIOPSY MARKET, BY REGION, 2019-2027 (UNITS)
TABLE 07.SERVICE BREAST CANCER LIQUID BIOPSY MARKET, BY REGION, 2019-2027 ($THOUSAND)
TABLE 08.SERVICE BREAST CANCER LIQUID BIOPSY MARKET, BY REGION, 2019-2027 (UNITS)
TABLE 09.BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 ($THOUSAND)
TABLE 10.BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 (UNITS)
TABLE 11.CIRCULATING TUMOR CELLS BREAST CANCER LIQUID BIOPSY MARKET, BY REGION, 2019-2027 ($THOUSAND)
TABLE 12.CIRCULATING TUMOR CELLS BREAST CANCER LIQUID BIOPSY MARKET, BY REGION, 2019-2027 (UNITS)
TABLE 13.EXTRACELLULAR VESICLES BREAST CANCER LIQUID BIOPSY MARKET, BY REGION, 2019-2027 ($THOUSAND)
TABLE 14.EXTRACELLULAR VESICLES BREAST CANCER LIQUID BIOPSY MARKET, BY REGION, 2019-2027 (UNITS)
TABLE 15.CIRCULATING TUMOR DNA BREAST CANCER LIQUID BIOPSY MARKET, BY REGION, 2019-2027 ($THOUSAND)
TABLE 16.CIRCULATING TUMOR DNA BREAST CANCER LIQUID BIOPSY MARKET, BY REGION, 2019-2027 (UNITS)
TABLE 17.BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 ($THOUSAND)
TABLE 18.BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 (UNITS)
TABLE 19.DIAGNOSTICS BREAST CANCER LIQUID BIOPSY MARKET, BY REGION, 2019-2027 ($THOUSAND)
TABLE 20.DIAGNOSTICS BREAST CANCER LIQUID BIOPSY MARKET, BY REGION, 2019-2027 (UNITS)
TABLE 21.PROGNOSTICS BREAST CANCER LIQUID BIOPSY MARKET, BY REGION, 2019-2027 ($THOUSAND)
TABLE 22.PROGNOSTICS BREAST CANCER LIQUID BIOPSY MARKET, BY REGION, 2019-2027 (UNITS)
TABLE 23.RISK ASSESSMENT BREAST CANCER LIQUID BIOPSY MARKET, BY REGION, 2019-2027 ($THOUSAND)
TABLE 24.RISK ASSESSMENT BREAST CANCER LIQUID BIOPSY MARKET, BY REGION, 2019-2027 (UNITS)
TABLE 25.BREAST CANCER LIQUID BIOPSY MARKET, BY REGION, 2019-2027 ($THOUSAND)
TABLE 26.BREAST CANCER LIQUID BIOPSY MARKET, BY REGION, 2019-2027 (UNITS)
TABLE 27.NORTH AMERICA BREAST CANCER LIQUID BIOPSY MARKET, BY COUNTRY, 2019-2027 ($THOUSAND)
TABLE 28.NORTH AMERICA BREAST CANCER LIQUID BIOPSY MARKET, BY COUNTRY, 2019-2027 (UNITS)
TABLE 29.U.S. BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 ($THOUSAND)
TABLE 30.U.S. BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 (UNITS)
TABLE 31.U.S. BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 ($THOUSAND)
TABLE 32.U.S. BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 (UNITS)
TABLE 33.U.S. BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 ($THOUSAND)
TABLE 34.U.S. BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 (UNITS)
TABLE 35.CANADA BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 ($THOUSAND)
TABLE 36.CANADA BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 (UNITS)
TABLE 37.CANADA BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 ($THOUSAND)
TABLE 38.CANADA BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 (UNITS)
TABLE 39.CANADA BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 ($THOUSAND)
TABLE 40.CANADA BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 (UNITS)
TABLE 41.MEXICO BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 ($THOUSAND)
TABLE 42.MEXICO BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 (UNITS)
TABLE 43.MEXICO BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 ($THOUSAND)
TABLE 44.MEXICO BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 (UNITS)
TABLE 45.MEXICO BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 ($THOUSAND)
TABLE 46.MEXICO BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 (UNITS)
TABLE 47.NORTH AMERICA BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 ($THOUSAND)
TABLE 48.NORTH AMERICA BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 (UNITS)
TABLE 49.NORTH AMERICA BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 ($THOUSAND)
TABLE 50.NORTH AMERICA BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 (UNITS)
TABLE 51.NORTH AMERICA BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 ($THOUSAND)
TABLE 52.NORTH AMERICA BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 (UNITS)
TABLE 53.EUROPE BREAST CANCER LIQUID BIOPSY MARKET, BY COUNTRY, 2019-2027 ($THOUSAND)
TABLE 54.EUROPE BREAST CANCER LIQUID BIOPSY MARKET, BY COUNTRY, 2019-2027 (UNITS)
TABLE 55.GERMANY BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 ($THOUSAND)
TABLE 56.GERMANY BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 (UNITS)
TABLE 57.GERMANY BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 ($THOUSAND)
TABLE 58.GERMANY BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 (UNITS)
TABLE 59.GERMANY BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 ($THOUSAND)
TABLE 60.GERMANY BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 (UNITS)
TABLE 61.FRANCE BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 ($THOUSAND)
TABLE 62.FRANCE BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 (UNITS)
TABLE 63.FRANCE BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 ($THOUSAND)
TABLE 64.FRANCE BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 (UNITS)
TABLE 65.FRANCE BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 ($THOUSAND)
TABLE 66.FRANCE BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 (UNITS)
TABLE 67.UK BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 ($THOUSAND)
TABLE 68.UK BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 (UNITS)
TABLE 69.UK BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 ($THOUSAND)
TABLE 70.UK BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 (UNITS)
TABLE 71.UK BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 ($THOUSAND)
TABLE 72.UK BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 (UNITS)
TABLE 73.ITALY BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 ($THOUSAND)
TABLE 74.ITALY BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 (UNITS)
TABLE 75.ITALY BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 ($THOUSAND)
TABLE 76.ITALY BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 (UNITS)
TABLE 77.ITALY BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 ($THOUSAND)
TABLE 78.ITALY BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 (UNITS)
TABLE 79.SPAIN BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 ($THOUSAND)
TABLE 80.SPAIN BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 (UNITS)
TABLE 81.SPAIN BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 ($THOUSAND)
TABLE 82.SPAIN BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 (UNITS)
TABLE 83.SPAIN BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 ($THOUSAND)
TABLE 84.SPAIN BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 (UNITS)
TABLE 85.REST OF EUROPE BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 ($THOUSAND)
TABLE 86.REST OF EUROPE BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 (UNITS)
TABLE 87.REST OF EUROPE BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 ($THOUSAND)
TABLE 88.REST OF EUROPE BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 (UNITS)
TABLE 89.REST OF EUROPE BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 ($THOUSAND)
TABLE 90.REST OF EUROPE BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 (UNITS)
TABLE 91.EUROPE BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 ($THOUSAND)
TABLE 92.EUROPE BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 (UNITS)
TABLE 93.EUROPE BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 ($THOUSAND)
TABLE 94.EUROPE BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 (UNITS)
TABLE 95.EUROPE BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 ($THOUSAND)
TABLE 96.EUROPE BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 (UNITS)
TABLE 97.ASIA-PACIFIC BREAST CANCER LIQUID BIOPSY MARKET, BY COUNTRY, 2019-2027 ($THOUSAND)
TABLE 98.ASIA-PACIFIC BREAST CANCER LIQUID BIOPSY MARKET, BY COUNTRY, 2019-2027 (UNITS)
TABLE 99.JAPAN BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 ($THOUSAND)
TABLE 100.JAPAN BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 (UNITS)
TABLE 101.JAPAN BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 ($THOUSAND)
TABLE 102.JAPAN BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 (UNITS)
TABLE 103.JAPAN BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 ($THOUSAND)
TABLE 104.JAPAN BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 (UNITS)
TABLE 105.CHINA BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 ($THOUSAND)
TABLE 106.CHINA BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 (UNITS)
TABLE 107.CHINA BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 ($THOUSAND)
TABLE 108.CHINA BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 (UNITS)
TABLE 109.CHINA BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 ($THOUSAND)
TABLE 110.CHINA BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 (UNITS)
TABLE 111.INDIA BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 ($THOUSAND)
TABLE 112.INDIA BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 (UNITS)
TABLE 113.INDIA BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 ($THOUSAND)
TABLE 114.INDIA BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 (UNITS)
TABLE 115.INDIA BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 ($THOUSAND)
TABLE 116.INDIA BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 (UNITS)
TABLE 117.REST OF ASIA-PACIFIC BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 ($THOUSAND)
TABLE 118.REST OF ASIA-PACIFIC BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 (UNITS)
TABLE 119.REST OF ASIA-PACIFIC BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 ($THOUSAND)
TABLE 120.REST OF ASIA-PACIFIC BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 (UNITS)
TABLE 121.REST OF ASIA-PACIFIC BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 ($THOUSAND)
TABLE 122.REST OF ASIA-PACIFIC BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 (UNITS)
TABLE 123.ASIA-PACIFIC BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 ($THOUSAND)
TABLE 124.ASIA-PACIFIC BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 (UNITS)
TABLE 125.ASIA-PACIFIC BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 ($THOUSAND)
TABLE 126.ASIA-PACIFIC BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 (UNITS)
TABLE 127.ASIA-PACIFIC BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 ($THOUSAND)
TABLE 128.ASIA-PACIFIC BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 (UNITS)
TABLE 129.LAMEA BREAST CANCER LIQUID BIOPSY MARKET, BY COUNTRY, 2019-2027 ($THOUSAND)
TABLE 130.LAMEA BREAST CANCER LIQUID BIOPSY MARKET, BY COUNTRY, 2019-2027 (UNITS)
TABLE 131.LATIN AMERICA BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 ($THOUSAND)
TABLE 132.LATIN AMERICA BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 (UNITS)
TABLE 133.LATIN AMERICA BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 ($THOUSAND)
TABLE 134.LATIN AMERICA BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 (UNITS)
TABLE 135.LATIN AMERICA BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 ($THOUSAND)
TABLE 136.LATIN AMERICA BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 (UNITS)
TABLE 137.MIDDLE EAST BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 ($THOUSAND)
TABLE 138.MIDDLE EAST BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 (UNITS)
TABLE 139.MIDDLE EAST BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 ($THOUSAND)
TABLE 140.MIDDLE EAST BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 (UNITS)
TABLE 141.MIDDLE EAST BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 ($THOUSAND)
TABLE 142.MIDDLE EAST BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 (UNITS)
TABLE 143.AFRICA BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 ($THOUSAND)
TABLE 144.AFRICA BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 (UNITS)
TABLE 145.AFRICA BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 ($THOUSAND)
TABLE 146.AFRICA BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 (UNITS)
TABLE 147.AFRICA BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 ($THOUSAND)
TABLE 148.AFRICA BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 (UNITS)
TABLE 149.LAMEA BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 ($THOUSAND)
TABLE 150.LAMEA BREAST CANCER LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2019-2027 (UNITS)
TABLE 151.LAMEA BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 ($THOUSAND)
TABLE 152.LAMEA BREAST CANCER LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2019-2027 (UNITS)
TABLE 153.LAMEA BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 ($THOUSAND)
TABLE 154.LAMEA BREAST CANCER LIQUID BIOPSY MARKET, BY APPLICATION, 2019-2027 (UNITS)
TABLE 155.BIOCEPT: COMPANY SNAPSHOT
TABLE 156.BIOCEPT: PRODUCT PORTFOLIO
TABLE 157.BIOCEPT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 158.ROCHE: COMPANY SNAPSHOT
TABLE 159.ROCHE: OPERATING SEGMENT
TABLE 160.ROCHE: PRODUCT PORTFOLIO
TABLE 161.ROCHE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 162.FLUXION: COMPANY SNAPSHOT
TABLE 163.FLUXION: PRODUCT PORTFOLIO
TABLE 164.MENARINI: COMPANY SNAPSHOT
TABLE 165.MENARINI: PRODUCT PORTFOLIO
TABLE 166.MENARINI: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 167.MYRIAD: COMPANY SNAPSHOT
TABLE 168.MYRIAD: OPERATING SEGMENTS
TABLE 169.MYRIAD: PRODUCT PORTFOLIO
TABLE 170.NEOGENOMICS: COMPANY SNAPSHOT
TABLE 171.NEOGENOMICS: OPERATING SEGMENT
TABLE 172.NEOGENOMICS: PRODUCT PORTFOLIO
TABLE 173.NEOGENOMICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 174.QIAGEN: COMPANY SNAPSHOT
TABLE 175.QIAGEN: OPERATING SEGMENT
TABLE 176.QIAGEN: PRODUCT PORTFOLIO
TABLE 177.QIAGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 178.SYSMEX: COMPANY SNAPSHOT
TABLE 179.SYSMEX: OERATING SEGMENT
TABLE 180.SYSMEX.: PRODUCT PORTFOLIO
TABLE 181.THERMO FISHER: COMPANY SNAPSHOT
TABLE 182.THERMO FISHER.: OPERATING SEGMENT
TABLE 183.THERMO FISHER.: PRODUCT PORTFOLIO
TABLE 184.GUARDANT: COMPANY SNAPSHOT
TABLE 185.GUARDANT: OPERATING SEGMENT
TABLE 186.GUARDANT: PRODUCT PORTFOLIO
TABLE 187.GUARDANT: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURE

LIST OF FIGURES

FIGURE 01.GLOBAL BREAST CANCER LIQUID BIOPSY MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2017-2019
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017-2019
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2017-2019
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.HIGH THREAT OF SUBSTITUTES
FIGURE 09.HIGH THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2019
FIGURE 12.TOP PLAYER POSITIONING, 2019
FIGURE 13.IMPACT ANALYSIS
FIGURE 14.COMPARATIVE ANALYSIS OF REAGENT KITS BREAST CANCER LIQUID BIOPSY MARKET, BY COUNTRY, 2019 & 2027 ($THOUSAND)
FIGURE 15.COMPARATIVE ANALYSIS OF REAGENT KITS BREAST CANCER LIQUID BIOPSY MARKET, BY COUNTRY, 2019 & 2027 (UNITS)
FIGURE 16.COMPARATIVE ANALYSIS OF INSTRUMENTS BREAST CANCER LIQUID BIOPSY MARKET, BY COUNTRY, 2019 & 2027 ($THOUSAND)
FIGURE 17.COMPARATIVE ANALYSIS OF INSTRUMENTS BREAST CANCER LIQUID BIOPSY MARKET, BY COUNTRY, 2019 & 2027 (UNITS)
FIGURE 18.COMPARATIVE ANALYSIS OF SERVICES BREAST CANCER LIQUID BIOPSY MARKET, BY COUNTRY, 2019 & 2027 ($THOUSAND)
FIGURE 19.COMPARATIVE ANALYSIS OF SERVICES BREAST CANCER LIQUID BIOPSY MARKET, BY COUNTRY, 2019 & 2027 (UNITS)
FIGURE 20.COMPARATIVE ANALYSIS OF CIRCULATING TUMOR CELLS BREAST CANCER LIQUID BIOPSY MARKET, BY COUNTRY, 2019 & 2027 ($THOUSAND)
FIGURE 21.COMPARATIVE ANALYSIS OF CIRCULATING TUMOR CELLS BREAST CANCER LIQUID BIOPSY MARKET, BY COUNTRY, 2019 & 2027 (UNITS)
FIGURE 22.COMPARATIVE ANALYSIS OF EXTRACELLULAR VESICLES BREAST CANCER LIQUID BIOPSY MARKET, BY COUNTRY, 2019 & 2027 ($THOUSAND)
FIGURE 23.COMPARATIVE ANALYSIS OF EXTRACELLULAR VESICLES BREAST CANCER LIQUID BIOPSY MARKET, BY COUNTRY, 2019 & 2027 (UNITS)
FIGURE 24.COMPARATIVE ANALYSIS OF CIRCULATING TUMOR DNA BREAST CANCER LIQUID BIOPSY MARKET, BY COUNTRY, 2019 & 2027 ($THOUSAND)
FIGURE 25.COMPARATIVE ANALYSIS OF CIRCULATING TUMOR DNA BREAST CANCER LIQUID BIOPSY MARKET, BY COUNTRY, 2019 & 2027 (UNITS)
FIGURE 26.COMPARATIVE ANALYSIS OF DIAGNOSTICS BREAST CANCER LIQUID BIOPSY MARKET, BY COUNTRY, 2019 & 2027 ($THOUSAND)
FIGURE 27.COMPARATIVE ANALYSIS OF DIAGNOSTICS BREAST CANCER LIQUID BIOPSY MARKET, BY COUNTRY, 2019 & 2027 (UNITS)
FIGURE 28.COMPARATIVE ANALYSIS OF PROGNOSTICS BREAST CANCER LIQUID BIOPSY MARKET, BY COUNTRY, 2019 & 2027 ($THOUSAND)
FIGURE 29.COMPARATIVE ANALYSIS OF PROGNOSTICS BREAST CANCER LIQUID BIOPSY MARKET, BY COUNTRY, 2019 & 2027 (UNITS)
FIGURE 30.COMPARATIVE ANALYSIS OF RISK ASSESSMENT BREAST CANCER LIQUID BIOPSY MARKET, BY COUNTRY, 2019 & 2027 ($THOUSAND)
FIGURE 31.COMPARATIVE ANALYSIS OF RISK ASSESSMENT BREAST CANCER LIQUID BIOPSY MARKET, BY COUNTRY, 2019 & 2027 (UNITS)
FIGURE 32.BIOCEPT: NET SALES, 2017-2019 ($MILLION)
FIGURE 33.ROCHE: NET SALES, 2017-2019 ($MILLION)
FIGURE 34.ROCHE: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 35.ROCHE: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 36.MYRIAD: NET SALES, 2018-2020 ($MILLION)
FIGURE 37.MYRIAD: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 38.NEOGENOMICS: NET SALES, 2017-2019 ($MILLION)
FIGURE 39.NEOGENOMICS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 40.QIAGEN: NET SALES, 2017-2019 ($MILLION)
FIGURE 41.QIAGEN: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 42.QIAGEN: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 43.SYSMEX: NET SALES, 2017-2019 ($MILLION)
FIGURE 44.SYSMEX: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 45.SYSMEX: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 46.THERMO FISHER: NET SALES, 2017-2019 ($MILLION)
FIGURE 47.THERMO FISHER: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 48.THERMO FISHER: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 49.GUARDANT: NET SALES, 2017-2019 ($MILLION)
FIGURE 50.GUARDANT: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 51.GUARDANT: REVENUE SHARE, BY REGION, 2019 (%)